Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Parkinson's Disease

  Free Subscription


18.12.2017

1 Brain Res
1 J Neural Transm (Vienna)
1 J Neurol Neurosurg Psychiatry
1 J Neurosci
1 Neurology
2 Neurosci Lett
1 PLoS Genet
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Rev Neurol
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Brain Res

  1. KELM-NELSON CA, Brauer AFL, Barth KJ, Lake JM, et al
    Characterization of early-onset motor deficits in the Pink1 -/- mouse model of Parkinson disease.
    Brain Res. 2017 Dec 8. pii: S0006-8993(17)30536.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  2. JELLINGER KA
    Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    J Neural Transm (Vienna). 2017 Dec 8. pii: 10.1007/s00702-017-1821.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  3. RODRIGUEZ-ROJAS R, Carballo-Barreda M, Alvarez L, Guridi J, et al
    Subthalamotomy for Parkinson's disease: clinical outcome and topography of lesions.
    J Neurol Neurosurg Psychiatry. 2017 Dec 8. pii: jnnp-2017-316241.
    PubMed     Text format     Abstract available


    J Neurosci

  4. PINTO M, Nissanka N, Moraes CT
    Lack of Parkin anticipates the phenotype and affects mitochondrial morphology and mtDNA levels in a mouse model of Parkinson's Disease.
    J Neurosci. 2017 Dec 8. pii: JNEUROSCI.1384-17.2017.
    PubMed     Text format     Abstract available


    Neurology

  5. BROCKMANN K, Lerche S, Dilger SS, Stirnkorb JG, et al
    SNPs in Abeta clearance proteins: Lower CSF Abeta1-42 levels and earlier onset of dementia in PD.
    Neurology. 2017;89:2335-2340.
    PubMed     Text format     Abstract available


    Neurosci Lett

  6. BREZA M, Koutsis G, Karadima G, Potagas C, et al
    The different faces of the p. A53T alpha-synuclein mutation: a screening of Greek patients with parkinsonism and/or dementia.
    Neurosci Lett. 2017 Dec 9. pii: S0304-3940(17)30988.
    PubMed     Text format     Abstract available

  7. AN C, Pu X, Xiao W, Zhang H, et al
    Expression of the DJ-1 protein in the serum of Chinese patients with Parkinson's disease.
    Neurosci Lett. 2017;665:236-239.
    PubMed     Text format     Abstract available


    PLoS Genet

  8. FERNANDEZ MV, Kim JH, Budde JP, Black K, et al
    Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.
    PLoS Genet. 2017;13:e1007045.
    PubMed     Text format     Abstract available


    PLoS One

  9. NICOLETTI A, Mostile G, Stocchi F, Abbruzzese G, et al
    Factors influencing psychological well-being in patients with Parkinson's disease.
    PLoS One. 2017;12:e0189682.
    PubMed     Text format     Abstract available

  10. GODINO-LLORENTE JI, Shattuck-Hufnagel S, Choi JY, Moro-Velazquez L, et al
    Towards the identification of Idiopathic Parkinson's Disease from the speech. New articulatory kinetic biomarkers.
    PLoS One. 2017;12:e0189583.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  11. BRAGG DC, Mangkalaphiban K, Vaine CA, Kulkarni NJ, et al
    Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in TAF1.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1712526114.
    PubMed     Text format     Abstract available


    Rev Neurol

  12. TABERNERO ME, Musich F, Cossini FC, Politis DG, et al
    [Social cognition in Parkinson's disease dementia and behavioral variant of frontotemporal dementia].
    Rev Neurol. 2017;65:539-545.
    PubMed     Text format     Abstract available


    Science

  13. SHIELDS BC, Kahuno E, Kim C, Apostolides PF, et al
    Deconstructing behavioral neuropharmacology with cellular specificity.
    Science. 2017;356.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: